Currently, the most extensively studied methylation-based markers in prostate cancer are the hypermethylated glutathione S-transferase P1 (GSTP1) and Ras-association domain family protein isoform A (RASSF1A). This evidence concerns the gene RASSF1 and prostate carcinoma.